What are the treatment options and investigations for Meniere's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment and Investigations for Meniere's Disease

For patients with Meniere's disease, first-line treatment should include lifestyle modifications (low-sodium diet, limiting alcohol and caffeine), diuretics, and/or betahistine, with progression to intratympanic steroids for those not responsive to conservative treatment. 1, 2

Diagnostic Evaluation

Required Investigations

  • Detailed history focusing on:

    • Vertigo characteristics (spontaneous attacks lasting 20 minutes to 12 hours)
    • Fluctuating hearing symptoms
    • Tinnitus and aural fullness 1
  • Audiometric testing to document fluctuating low- to mid-frequency sensorineural hearing loss 1

  • Vestibular function tests:

    • Video/electronystagmography
    • Electrocochleography (measures electrical responses of cochlea)
    • Vestibular-evoked myogenic potential testing 1, 3
  • MRI of brain to:

    • Rule out other causes (e.g., vestibular schwannoma)
    • Potentially visualize endolymphatic hydrops 1

Treatment Algorithm

1. First-Line Treatment (Conservative Management)

  • Dietary and Lifestyle Modifications:

    • Low-sodium diet (1500-2300 mg daily)
    • Limit alcohol consumption
    • Limit caffeine intake
    • Identify and manage triggers (stress, allergies) 1, 2, 4
  • Pharmacological Options:

    • Diuretics to reduce fluid volume
    • Betahistine to increase inner ear blood flow 2, 1
    • Antivertigo medications for acute attacks 1
    • Antihistamines if allergies are contributing 1

2. Second-Line Treatment

  • Intratympanic steroids for patients with active Meniere's disease not responsive to noninvasive treatment 2, 1
    • Benefits: Improved vertigo control, improved quality of life, faster return to work 2
    • Risks: Hearing loss, eardrum perforation, persistent imbalance 2

3. Third-Line Treatment (Based on Hearing Status)

  • For patients with usable hearing:

    • Endolymphatic sac decompression 1, 5
    • Vestibular nerve section 1
  • For patients with non-usable hearing:

    • Intratympanic gentamicin (chemical labyrinthectomy) 1, 6, 5
    • Surgical labyrinthectomy (with or without cochlear implantation) 1, 5

Important Clinical Considerations

Effectiveness of Treatments

  • Positive pressure therapy should NOT be prescribed as it has been shown to be ineffective 2

  • Vestibular rehabilitation/physical therapy should NOT be recommended for managing acute vertigo attacks but may be beneficial during the intercritic period 2, 5

  • Betahistine and diuretics have shown benefit in observational studies, though evidence quality is moderate 2

Treatment Monitoring

  • Regular audiometric testing to track hearing loss progression
  • Document changes in vertigo frequency and severity
  • Assess impact on quality of life 1

Cautions and Pitfalls

  1. Diagnostic challenges: Meniere's disease can be confused with vestibular migraine, BPPV, or vestibular neuritis - careful attention to symptom patterns is essential 1

  2. Bilateral disease: Consider more conservative approaches as 10-25% of cases may become bilateral over time 2

  3. Sodium restriction risks: While recommended, monitor for hyponatremia, especially in elderly patients or those with comorbidities 2

  4. Intratympanic gentamicin risks: Can cause hearing loss; low-dose protocols are now preferred to balance vertigo control with hearing preservation 6

  5. Patient expectations: The disease course can be unpredictable with symptoms that may naturally fluctuate, making treatment efficacy assessment challenging 2, 1

The treatment approach should follow a stepwise progression, starting with conservative measures and advancing to more invasive options only when symptoms remain uncontrolled. Quality of life should be a primary consideration in treatment decisions, as the unpredictable nature of attacks can cause significant anxiety and social isolation 1.

References

Guideline

Diagnosis and Management of Ménière's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Meniere's disease.

Nature reviews. Disease primers, 2016

Research

International consensus (ICON) on treatment of Ménière's disease.

European annals of otorhinolaryngology, head and neck diseases, 2018

Research

Ménière's disease.

Current opinion in neurology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.